| Appendix 4C - Quarterly Cash Flow Report |
Apr 29, 2008 |
| Benitec secures further rights to HIV Therapeutic |
Apr 29, 2008 |
| Benitec wins in US Supreme Court |
Apr 22, 2008 |
| US Patent Reexam Update |
Apr 21, 2008 |
| Reinstatement to Official Quotation |
Apr 21, 2008 |
| Suspension from Official Quotation |
Apr 16, 2008 |
| Request for Voluntary Suspension |
Apr 16, 2008 |
| Trading Halt |
Apr 14, 2008 |
| Request for Trading Halt |
Apr 14, 2008 |
| Exercise of Options |
Apr 11, 2008 |
| Investor Update |
Apr 7, 2008 |
| Dr Rossi
presents update on HIV lymphoma study at Keystone meeting |
Mar 31, 2008 |
| Expiry of Unlisted Options |
Mar 27, 2008 |
| Benitec licensee’s Oncolys deal to commercialise Hep C drug |
Mar 13, 2008 |
| Benitec US Reexam Update |
Mar 12, 2008 |
| Change of Director's Interest Notice |
Mar 7, 2008 |
| Changes to Unlisted Options and Appendix 3B |
Mar 6, 2008 |
| Half Year Report and Accounts |
Feb 29, 2008 |
| Final Director's Interest Notice |
Feb 26, 2008 |
| Board Changes |
Feb 26, 2008 |
| Corporate Flyer Jan-08 |
Feb 5, 2008 |
| Presentation to BioPartnering North America |
Feb 5, 2008 |
| Benitec at BioPartnering North America meeting |
Feb 5, 2008 |
| Response to ASX Query |
Feb 5, 2008 |
| Appendix 4C - Quarterly Cash Flow Report |
Jan 30, 2008 |
| Ceasing to be a substantial shareholder |
Jan 10, 2008 |
| Update on Nucleonics Request to US Supreme Court |
Jan 10, 2008 |
| Response to ASX Query |
Jan 8, 2008 |
| Benitec's Licensee confirms Hepatitis C deal with Pfizer |
Jan 8, 2008 |
| Trading Halt |
Jan 8, 2008 |
| Trading Halt Request |
Jan 8, 2008 |
| Nucleonics files Request to US Supreme Court |
Jan 4, 2008 |
| Company Response to ASX Price Query |
Jan 3, 2008 |
| Change of Director's Interest Notice |
Dec 11, 2007 |
| Change of Director's Interest Notice |
Dec 6, 2007 |
| Change of Director's Interest Notice |
Dec 6, 2007 |
| Change of Director's Interest Notice |
Dec 6, 2007 |
| Appendix 3B Issue of Options |
Dec 6, 2007 |
| Change of Director's Interest Notice |
Dec 5, 2007 |
| Results of Meeting |
Nov 28, 2007 |
| Chairman's Address to Shareholders |
Nov 28, 2007 |
| Appendix 3B Exercise of Options |
Nov 2, 2007 |
| Shareholder acquires Additional Equity Stake |
Oct 31, 2007 |
| Appendix 3B Loan Conversion |
Oct 31, 2007 |
| 2007 Annual Report |
Oct 26, 2007 |
| Notice of Annual General Meeting |
Oct 26, 2007 |
| Appendix 4C - Quarterly Cash Flow Report |
Oct 26, 2007 |
| Benitec AusBiotech Conference Presentation |
Oct 23, 2007 |
| Benitec presents at National AusBiotech Conference |
Oct 23, 2007 |
| Initial Director's Interest Notice |
Oct 16, 2007 |
| Investor Presentation for US Roadshow |
Oct 15, 2007 |
| Benitec conducts US roadshow |
Oct 15, 2007 |
| Benitec appoints Mel Bridges Non-Executive Director |
Oct 12, 2007 |
| Notice of Initial Substantial Holder |
Oct 11, 2007 |
| Benitec Investor Presentation Oct-07 |
Oct 10, 2007 |
| Benitec presents at Intersuisse Asia Pacific LifeScience Forum |
Oct 10, 2007 |
| US-based Promega Corp acquires additional equity stake |
Oct 8, 2007 |
| Appendix 3B Conversion of Promissory Note |
Oct 8, 2007 |
| Benitec at BioPartnering Europe Meeting |
Oct 8, 2007 |
| Nucleonics petition denied in US Court |
Oct 5, 2007 |
| Full Year Statutory Accounts 2007 |
Sep 5, 2007 |
| Preliminary Final Report for Year ended 30 June 2007 |
Aug 31, 2007 |
| Share Registry Change of Location |
Aug 30, 2007 |
| Appendix 3B ESOP Options |
Aug 30, 2007 |
| Benitec appoints Chief Scientific Officer |
Aug 21, 2007 |
| Benitec MOU with CalbaTech, Inc. |
Aug 17, 2007 |
| Investor Update |
Aug 9, 2007 |
| Initial Director's Interest Notice |
Aug 8, 2007 |
| Patent Reexam and Litigation Update |
Aug 8, 2007 |
| Commitments Test Entity - Fourth Quarter Report |
July 31, 2007 |
| Benitec wins in US Court |
July 23, 2007 |
| CEO of Benitec joins Board |
July 2, 2007 |
| New Benitec website: better investor communications |
June 27, 2007 |
| Benitec appoints new Scientific Advisory Board |
June 20, 2007 |
| Commences HIV Study in Humans in Los Angeles |
June 13, 2007 |
| Change of Director's Interest Notice x 2 |
May 14, 2007 |
| Change in substantial holding |
May 11, 2007 |
| Benitec bio-partnering at BIO2007 |
May 7, 2007 |
| Benitec features at prestigious Boston meeting |
May 4, 2007 |
| Commitments Test Entity - Third Quarter Report |
April 30, 2007 |
| London Investor Update |
April 27, 2007 |
| Files US Patent Response |
April 26, 2007 |
| European Patent Update |
April 26, 2007 |
| Investor Update |
April 16, 2007 |
| Change in substantial holding |
April 13, 2007 |
| New CFO Appointed |
April 13, 2007 |
| Change in substantial holding |
April 13, 2007 |
| Completion of Rights Issue & Top 20 Share & Option holders |
April 4, 2007 |
| Phase I Study Update |
April 2, 2007 |
| Becoming a substantial holder |
April 2, 2007 |
| Becoming a substantial holder |
April 2, 2007 |
| Shortfall in Rights Issue |
March 29, 2007 |
| Patent Re-examination Update |
March 16, 2007 |
| Non-Renounceable Issue |
March 5, 2007 |
| Becoming a substantial holder |
March 2, 2007 |
| Half Year Accounts |
March 1, 2007 |
| Half Yearly Report |
March 1, 2007 |
| Preliminary Half Year Report for Period Ending 31 December 2006 |
February 28, 2007 |
| Rights Issue Prospectus |
February 28, 2007 |
| Rights Issue Announcement |
February 26, 2007 |
| Benitec Options Update |
February 26, 2007 |
| Results of General Meeting |
February 21, 2007 |
| Benitec Patent and Litigation Update |
February 13, 2007 |
| Benitec Patent Re-examination Update |
February 6, 2007 |
| Trading Halt |
January 30, 2007 |
| Quarterly Report for Entities admitted on the basis of commitments |
January 30, 2007 |
| Additional Information for General Meeting |
January 8, 2007 |
| Sigma-Aldrich licences Pfizer to use Benitec Technology |
January 5, 2007 |
| Revised Notice of General Meeting |
January 5, 2007 |
| Benitec Receives $650k Investment Support |
January 3, 2007 |
| John Rawling Appointed as Co-Company Secretary and Accountant |
January 3, 2007 |
| Notice of General Meeting |
January 3, 2007 |
| Change in substantial holding |
December 28, 2006 |
| Results of AGM |
December 28, 2006 |
| CEO Presentation |
November 30, 2006 |
| Chairman's Address to Shareholders |
November 30, 2006 |
| Additional Information for AGM |
November 30, 2006 |
| Presentation at AusBiotech National Biotech Conference |
November 30, 2006 |
| Final Annual Report 2006 |
October 31, 2006 |
| Commentary on Benitec Ltd Share Price |
October 31, 2006 |
| Additional Information Re ASX Price Query |
October 30, 2006 |
| Response to ASX Share Price Query |
October 25, 2006 |
| Commitments Test Entity - First Quarter Report |
October 23, 2006 |
| Notice of Annual General Meeting |
October 23, 2006 |
| Reinstatement to Official Quotation |
October 17, 2006 |
| Full Year Statutory Accounts 2006 |
October 17, 2006 |
| Ceasing to be a Substantial Shareholder |
October 11, 2006 |
| Benitec Secures New Investment Support |
October 11, 2006 |
| Benitec Executes New RNAi License Deal with Tacere Therapeutics |
October 10, 2006 |
| Appendix 3B - New Issue Announcement |
October 6, 2006 |
| US-Based Promega Corp Acquires Equity Stake in Benitec |
September 29, 2006 |
| Benitec Update on Audited Accounts |
September 25, 2006 |
| Benitec Accounts Update |
September 14, 2006 |
| Benitec Appoints Paul McMahon as CFO & Company Secretary |
September 14, 2006 |
| Change in substantial holding |
September 11, 2006 |
| Preliminary Final Report |
August 28, 2006 |
| Share Purchase Plan |
August 25, 2006 |
| Benitec Appoints Sue MacLeman as CEO |
August 22, 2006 |
| Benitec Announces Share Purchase Plan Extension Offer |
August 8, 2006 |
| Benitec negotiates reduced CSIRO royalties |
August 8, 2006 |
| Revised Share Purchase Plan Application Form |
August 8, 2006 |
| Revised Shareholder Share Purchase Plan |
July 31, 2006 |
| Share Purchase Plan - Pricing Restructure |
July 26, 2006 |
| Commitments Test Entity - Fourth Quarter Report |
July 26, 2006 |
| Shareholder Share Purchase Plan |
July 26, 2006 |
| Letter to Shareholders Regarding Share Purchase Plan |
June 29, 2006 |
| News Release: Share Purchase Plan |
June 29, 2006 |
| Final Director's Interest Notice - Michael Catelani |
June 22, 2006 |
| Final Director's Interest Notice - Sara Cunningham |
June 22, 2006 |
| Benitec Resumes Manufacturing of HIV/AIDS Therapeutic |
June 5, 2006 |
Benitec Shuts Down U.S. Operations and Restructures Board
|
May 25, 2006 |
| Benitec to Present at the American Society of Gene Therapy 9th Annual Meeting |
May 23, 2006 |
| Benitec Provides Context for Nature Paper on RNAi |
May 22, 2006 |
| Half Yearly Report Clarification |
May 10, 2006 |
| Final Director's Interest Notice - Alexander Cappello |
April 28, 2006 |
| New Issue Announcement - Appendix 3B |
April 18, 2006 |
| Commitments Test Entity - Third Quarter Report |
April 18, 2006 |
| Benitec featured on ABC-TV’S Catalyst |
April 17, 2006 |
| Benitec Implements Cost Reductions |
April 11, 2006 |
| Director Resignation - Alex Cappello |
April 4, 2006 |
Ceasing to be a substantial holder - Barbary Coast Investments
Benitec Featured in BioPharm International Biopartnering Down Under article |
March 24, 2006 |
| Benitec Announces Appointment of Dr. Mike Dalling to its Board of Directors |
March 24, 2006 |
| Benitec Announces Appointment of Peter Francis as Chairman of the Board of Directors |
February 23, 2006 |
| Benitec Announces Appointment of Company Secretary and Change of Registered Address |
February 23, 2006 |
| Benitec Appoints Two New Directors |
February 8, 2006 |
| Benitec Delays IND Filing for HIV/AIDS Therapeutic Pending Resolution of Manufacturing Result. |
January 30, 2006 |
